Sebastien Ribault
Corporate Officer/Principal chez OXFORD BIOMEDICA PLC
Profil
Sebastien Ribault is currently the Chairman at Merck Biodevelopment SAS, Director at Cell-Easy SAS (starting in 2023), and Chief Commercial Officer at Oxford Biomedica Plc (starting in 2022).
Previously, he worked as the Head of Research & Development Laboratory at Hemosystem SA. He obtained a doctorate degree from the University of Strasbourg.
Postes actifs de Sebastien Ribault
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/01/2022 |
Merck Biodevelopment SAS
 Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The private company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Chairman | - |
Cell-Easy SAS
 Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Director/Board Member | 11/05/2023 |
Anciens postes connus de Sebastien Ribault
| Sociétés | Poste | Fin |
|---|---|---|
Hemosystem SA
 Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Corporate Officer/Principal | - |
Formation de Sebastien Ribault
| University of Strasbourg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Hemosystem SA
Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Health Technology |
Merck Biodevelopment SAS
Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The private company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Commercial Services |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Commercial Services |
